Paracetamol IV (Burns Multimodal Analgesia)
Brand names: Perfalgan
Adult dose
Paediatric dose
Dose adjustments
No dose adjustment for eGFR >30. Severe renal failure: extend dosing interval to 8 hours and monitor.
Avoid in severe hepatic impairment (Child-Pugh C) — dramatically reduced glutathione stores increase hepatotoxicity risk at standard doses. Moderate impairment: max 3 g/day, reduce dosing interval.
Neonates (32–44 weeks corrected): 7.5 mg/kg every 6–8 hours. Children 28–32 weeks corrected gestation: 7.5 mg/kg every 12 hours. BNFc dose tables by weight and gestational age.
Clinical pearls
- MHRA warning — flucloxacillin-paracetamol HOGW acidosis: this combination (common in burns patients — flucloxacillin for wound prophylaxis + paracetamol IV) has been linked to high-anion gap metabolic acidosis of unclear mechanism; MHRA 2021 updated guidance — monitor acid-base status in patients on prolonged combined therapy
- Scheduled around-the-clock dosing superiority: PRN paracetamol is inferior to scheduled dosing in burns — background pain is constant; scheduled 4× daily IV paracetamol provides sustained plasma levels and reduces opioid consumption; BBA guidelines recommend scheduled rather than PRN
- Oral vs IV in acute burns: during the acute phase (first 48–72h) with GI oedema, ileus, and fluid shifts — oral absorption is unreliable; IV formulation preferred until GI function normalises; then step down to oral. Cost: IV paracetamol is significantly more expensive than oral — use only when genuinely indicated
Contraindications
- Severe hepatic impairment
- Paracetamol hypersensitivity
- Concomitant paracetamol in any form (combination products — risk of accidental overdose)
Side effects
- Hepatotoxicity (overdose or severe hepatic impairment — dose-dependent; via NAPQI metabolite)
- Hypotension (during IV infusion — uncommon; due to vasodilation)
- Elevated LFTs (rarely at standard doses)
- Thrombocytopenia (very rare)
Interactions
- Warfarin (paracetamol >2 g/day regularly raises INR via reduction of clotting factor synthesis — monitor INR in burns patients on warfarin)
- Hepatotoxic drugs (alcohol, isoniazid, rifampicin — increase NAPQI production; reduce daily limit)
- Flucloxacillin (IV flucloxacillin plus paracetamol — HOGW syndrome: high anion gap metabolic acidosis; mechanism unclear; monitor in burns patients on both)
Monitoring
- Daily paracetamol dose (cumulative — check all sources; multimodal regimens often include combination products)
- LFTs (especially if hepatic risk factors or flucloxacillin co-prescription)
- Acid-base status (HOGW acidosis signal with flucloxacillin combination)
- Pain scores (efficacy assessment)
Reference: BNFc; BNF 90; BNFc; British Burns Association Analgesia Guidelines 2018; MHRA Drug Safety Update 2021 (flucloxacillin + paracetamol); NICE NG24 (Burns). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
- Parkland Formula for Burns Fluid Resuscitation · Burns
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) for Pain · Pain Assessment
- TBSA — Total Body Surface Area Burned (Rule of Nines) · Formula
- Lund-Browder Chart — TBSA Burn Estimation · Burns